Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NANOFACTS

Financiado

Cerrado

Networking Activities for Nanotechnology Facilitated Cancer Theranostics

The main goal of NANOFACTS is to efficiently overcome the networking gaps and deficiencies in research capabilities and collaboration regarding research in cancer theranostics nanomaterials and biosensing diagnostics of cancer, be... ver más

30/06/2024

BIOSENSE INSTITUTE

900K€

Presupuesto del proyecto: 900K€

Líder del proyecto

BIOSENSE INSTITUTE RESEARCH AND DEVELOPMENT... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 3 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2024-06-30

WIDESPREAD-05-2020: Twinning

I+D

Cerrada hace 5 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

3 Participantes

BIOSENSE INSTITUTE

411.50K€ | Lider

TU WIEN

230.67K€ | Participante

TRINITY COLLEGE DUBLIN

257.66K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

EUIN2015-62619 DISPOSITIVOS EN LA FRONTERA DE NANOMECANICA Y NANOOPTICA PAR... 10K€ Cerrado

RYC-2016-20299 Nanotechnologies in biomedicine: point-of-care diagnostic sy... 309K€ Cerrado

RYC-2017-21640 Merging nanomechanical systems with other nanotechnologies t... 309K€ Cerrado

NanoIntra Multitasking Nanoparticles for Intracellular Bioimaging and... 259K€ Cerrado

PTQ-08-01-06839 ONCNOSIS NANOTECH: DESARROLLO DE BIOCHIPS PARA EL ANÁLISIS D... 61K€ Cerrado

RYC-2015-17345 Bioengineered Nanoparticles for Biosensing Applications 309K€ Cerrado

Duración del proyecto: 48 meses Fecha Inicio: 2020-06-11
Fecha Fin: 2024-06-30

Líder del proyecto

BIOSENSE INSTITUTE RESEARCH AND DEVELOPMENT... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 900K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The main goal of NANOFACTS is to efficiently overcome the networking gaps and deficiencies in research capabilities and collaboration regarding research in cancer theranostics nanomaterials and biosensing diagnostics of cancer, between BIOS and the partner institutions, internationally-leading counterparts at EU level, leading to the enhanced scientific and technological (S&T) capacity of all the participating institutions with a principal focus on BIOS. In order to widen the research agenda at BIOS with cancer-related research and health-related biosensing technologies, NANOFACTS will harness and improve pre-existing links with two leading European research institutions in the field of nanotechnology and development of biosensors: • Trinity College Dublin (TCD), Ireland, The School of Pharmacy and Pharmaceutical Sciences, an expert in application of nanotechnology for cancer treatment and imaging; and its validation, including biocompatibility of nanoparticles/nanodevices. • Vienna University of Technology (TUW), Faculty of Technical Chemistry, Institute of Applied Synthetic Chemistry and Institute of Chemical Technologies and Analytics, an expert in devising health-related biosensors. The main strategies to be explored during the project activities will include: a) BIOS researchers gaining knowledge on devising theranostic nanoparticles for real-time in vivo detection of cancer biomarkers, along with simultaneous targeted cancer therapy and imaging and b) enhancing the capacity of biosensing technologies at BIOS with cancer-related biosensing, including construction of an array of user-friendly personalized point of-care microfluidic and electronic diagnostic devices for electronic and optical sensing of cancer biomarkers, which could be introduced to home disease-monitoring. Complementarity of the consortium is based on the diversity of the expertise, knowledge and access to the stakeholder communities required for the success of the project.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores